Foley Hoag Represents Sekisui Diagnostics in Strategic Partnership with Qualigen
May 13, 2016
Foley Hoag LLP recently represented global diagnostics company Sekisui Diagnostics, LLC in the development of its strategic partnership with Qualigen Incorporated, a leader in the medical diagnostic products industry. Under the agreement, Sekisui Diagnostics will collaborate with Qualigen on current and future business opportunities and become the commercial partner for the Qualigen FastPack® IP System, a state of the art, lab quality analyzer that produces "Just in Time" quantitative test results quickly and easily.
Headquartered in Lexington, MA, Sekisui Diagnostics provides clinical chemistry and coagulation systems, reagents, infectious disease testing and rapid test kits, as well as enzymes and specialty bio-chemicals to physicians and laboratories through its global commercial network. The agreement with Qualigen will add to Sekisui Diagnostics' portfolio in the physician office laboratories market.
Foley Hoag partner Mark Haddad advised Sekisui Diagnostics in the transaction, with assistance from associate Craig Randall.
About Foley Hoag LLP
Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and staff contribute to the exceptional senior level service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.